Literature DB >> 29062546

Precision Medicine: Where have we reached and where are we headed?

Ikram A Burney1, Ritu Lakhtakia2.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 29062546      PMCID: PMC5642353          DOI: 10.18295/squmj.2017.17.03.001

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


× No keyword cloud information.
  20 in total

1.  IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.

Authors:  D G Maloney; A J Grillo-López; C A White; D Bodkin; R J Schilder; J A Neidhart; N Janakiraman; K A Foon; T M Liles; B K Dallaire; K Wey; I Royston; T Davis; R Levy
Journal:  Blood       Date:  1997-09-15       Impact factor: 22.113

Review 2.  What is personalized medicine and what should it replace?

Authors:  David C Whitcomb
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-22       Impact factor: 46.802

3.  Limits to Personalized Cancer Medicine.

Authors:  Ian F Tannock; John A Hickman
Journal:  N Engl J Med       Date:  2016-09-29       Impact factor: 91.245

4.  Immunologic characterization of human malignant lymphomas.

Authors:  R J Lukes; R D Collins
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

5.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

6.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

7.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

8.  Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

Authors:  B J Druker; M Talpaz; D J Resta; B Peng; E Buchdunger; J M Ford; N B Lydon; H Kantarjian; R Capdeville; S Ohno-Jones; C L Sawyers
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

Review 9.  The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy.

Authors:  Jeffrey S Ross; Jonathan A Fletcher; Gerald P Linette; James Stec; Edward Clark; Mark Ayers; W Fraser Symmans; Lajos Pusztai; Kenneth J Bloom
Journal:  Oncologist       Date:  2003

10.  The consensus molecular subtypes of colorectal cancer.

Authors:  Justin Guinney; Rodrigo Dienstmann; Xin Wang; Aurélien de Reyniès; Andreas Schlicker; Charlotte Soneson; Laetitia Marisa; Paul Roepman; Gift Nyamundanda; Paolo Angelino; Brian M Bot; Jeffrey S Morris; Iris M Simon; Sarah Gerster; Evelyn Fessler; Felipe De Sousa E Melo; Edoardo Missiaglia; Hena Ramay; David Barras; Krisztian Homicsko; Dipen Maru; Ganiraju C Manyam; Bradley Broom; Valerie Boige; Beatriz Perez-Villamil; Ted Laderas; Ramon Salazar; Joe W Gray; Douglas Hanahan; Josep Tabernero; Rene Bernards; Stephen H Friend; Pierre Laurent-Puig; Jan Paul Medema; Anguraj Sadanandam; Lodewyk Wessels; Mauro Delorenzi; Scott Kopetz; Louis Vermeulen; Sabine Tejpar
Journal:  Nat Med       Date:  2015-10-12       Impact factor: 53.440

View more
  5 in total

Review 1.  Patient-derived xenograft models for personalized medicine in colorectal cancer.

Authors:  Jun Xie; Yan Lin
Journal:  Clin Exp Med       Date:  2020-02-25       Impact factor: 3.984

Review 2.  Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma.

Authors:  Revati Sharma; George Kannourakis; Prashanth Prithviraj; Nuzhat Ahmed
Journal:  Front Med (Lausanne)       Date:  2022-06-14

3.  Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer.

Authors:  Xuan Huang; Chuanjun Shu; Li Chen; Bing Yao
Journal:  Oncol Rep       Date:  2018-06-27       Impact factor: 3.906

4.  Promoter Methylation of Selected Genes in Non-Small-Cell Lung Cancer Patients and Cell Lines.

Authors:  Victoria Sarne; Samuel Huter; Sandrina Braunmueller; Lisa Rakob; Nico Jacobi; Melitta Kitzwögerer; Christoph Wiesner; Peter Obrist; Rita Seeboeck
Journal:  Int J Mol Sci       Date:  2020-06-28       Impact factor: 5.923

5.  The growing role of precision and personalized medicine for cancer treatment.

Authors:  Paulina Krzyszczyk; Alison Acevedo; Erika J Davidoff; Lauren M Timmins; Ileana Marrero-Berrios; Misaal Patel; Corina White; Christopher Lowe; Joseph J Sherba; Clara Hartmanshenn; Kate M O'Neill; Max L Balter; Zachary R Fritz; Ioannis P Androulakis; Rene S Schloss; Martin L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2019-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.